The microenvironment in mantle cell lymphoma: Cellular and molecular pathways and emerging targeted therapies

Keyphrases

• Accessory Cells 16%
• Bone Marrow 16%
• Cell Survival 16%
• Cell-to-cell 16%
• Cellular Interactions 16%
• Cellular Pathways 100%
• Clinical Development 16%
• Clinical Trials 16%
• Conventional Treatment 16%
• Disease Progression 16%
• Drug Resistance 33%
• Growth Resistance 16%
• Lymphoma Cells 100%
• Lymphoma Microenvironment 16%
• Mantle Cell Lymphoma 100%
• Microenvironment 100%
• Molecular Interactions 16%
• Molecular Pathways 100%
• Residual Disease 16%
• Secondary Lymphoid Organs 16%
• Stromal Cells 16%
• Targeted Therapy 100%
• Tissue Microenvironment 16%
• Tissue Niche 16%

Medicine and Dentistry

• Accessory Cell 25%
• Cell Survival 25%
• Clinical Trial 25%
• Disease Exacerbation 25%
• Drug Resistance 50%
• Lymphoid Organ 25%
• Lymphoma Cell 50%
• Mantle Cell Lymphoma 100%
• Mantle Cell Lymphoma Cell 100%
• Minimal Residual Disease 25%
• Stromal Cell 25%
• Targeted Therapy 100%

Immunology and Microbiology

• Accessory Cell 25%
• Cell Interaction 25%
• Cell Survival 25%
• Drug Resistance 50%
• Lymphoid Organ 25%
• Lymphoma Cell 100%
• Mantle Cell Lymphoma Cell 100%
• Molecular Interaction 25%